This note is not part of the order, but is intended to indicate its general effect.
This order adds the drug commonly known as
“fantasy” to Part 1 of Schedule 2 of the Misuse of Drugs Act 1975. The effect of this is to classify fantasy a Class B controlled drug.
Fantasy (also known as GHB (gamma-hydroxybutyrate)) is a designer drug that has a number of chemically related substances that convert into GHB once in the human body. Because of this unusual characteristic, it is necessary to include in the classification not only the basic chemical substance (GHB), but also other substances that turn into fantasy once in the human body.
The classification of fantasy as a Class B controlled drug follows a recommendation to the Minister of Health by the Expert Advisory Committee of Drugs, which is established under section 5AA of the Misuse of Drugs Act 1975.
This order comes into force on a date to be set by a commencement order made under section 4A of the Misuse of Drugs Act 1975. That section provides that the commencement order may be made only after the House of Representatives has approved this classification order. Approval cannot be given until at least 28 days after the date on which this order is notified in the Gazette.
By a sessional order of the House of Representatives made on 16 November 2000, the House agreed that a notice of motion to approve a classification order stands referred to the Health Committee of the House. That Committee must report to the House within 28 days of the notice of motion being lodged.
Date of notification in Gazette: 13 December 2001.
This order is administered by the Ministry of Health.